Alnylam Pharmaceuticals reported $220.55M in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.22M 8.67M
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
Alnylam Pharmaceuticals ALNY:US $ 220.55M 42.99M
Amgen AMGN:US $ 6526M 625M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Arrowhead Research ARWR:US $ 45.89M 13.08M
Biocryst Pharmaceuticals BCRX:US $ 49.96M 30.9M
Biomarin Pharmaceutical BMRN:US $ 501.69M 15.66M
Bluebird Bio BLUE:US $ 7.47M 5.32M
Dicerna Pharmaceuticals DRNA:US $ 41.34M 6.27M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Intercept Pharmaceuticals ICPT:US $ 96.58M 14.92M
IONIS PHARMACEUT IONS:US $ 125.75M 14.14M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US 4.35B 2.42B
Neurocrine Biosciences NBIX:US $ 288.9M 52.3M
Novartis NVS:US $ 13294M 600M
Ptc Therapeutics PTCT:US $ 116.68M 1.27M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M
Regulus Therapeutics RGLS:US $ 0M 0M
Sangamo Biosciences SGMO:US $ 27.87M 1.59M
Sarepta Therapeutics SRPT:US $ 164.09M 17.16M
Takeda 4502:JP Y 949603M 179329M
Ultragenyx Pharmaceutical RARE:US $ 86.98M 12.42M
Vertex Pharmaceuticals VRTX:US $ 1793.37M 69.06M
Xencor XNCR:US $ 67.45M 33.48M
YTE INCY:US $ 705.71M 100.99M